Mycophenolate mofetil: Molecular mechanisms of action
- 1 August 1994
- journal article
- Published by Springer Nature in Perspectives in Drug Discovery and Design
- Vol. 2 (1) , 185-204
- https://doi.org/10.1007/bf02171743
Abstract
No abstract availableKeywords
This publication has 166 references indexed in Scilit:
- Cell cycle dependent regulation of IMP dehydrogenase activity and effect of tiazofurinLife Sciences, 1992
- 1-β-D-Ribofuranosyl-1,2,4-triazole-3-carboxamide (ribavirin) and 5-ethynyl-1-β-D-ribofuranosylimidazole-4-carboxamide (EICAR) markedly potentiate the inhibitory effect of 2′,3′-dideoxyinosine on human immunodeficiency virus in peripheral blood lymphocytesBiochemical and Biophysical Research Communications, 1991
- Regulation of IgE receptor-mediated secretion from RBL-2H3 mast cells by GTP binding-proteins and calciumBiochemical and Biophysical Research Communications, 1991
- Isolation and sequence of a cDNA encoding mouse IMP dehydrogenaseGene, 1991
- Cell differentiation and altered IMP dehydrogenase expression induced in human T-lymphoblastoid leukemia cells by mycophenolic acid and tiazofurinExperimental Cell Research, 1990
- Induction of the differentiation of synchronized HL-60 leukemia cells by tiazofurinExperimental Cell Research, 1989
- Mycophenolic acid for psoriasisJournal of the American Academy of Dermatology, 1987
- Purification of IMP dehydrogenase from rat hepatoma 3924ALife Sciences, 1987
- Induced maturation of the human promyelocytic leukemia cell line, HL-60, by 2-β-D-ribofuranosylselenazole-4-carboxamideBiochemical and Biophysical Research Communications, 1983
- Efficacy of mycophenolic acid for the treatment of psoriasisJournal of the American Academy of Dermatology, 1979